Medpace Holdings, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	706.6M	708.5M	659.9M	603.3M	558.6M	536.6M	533.3M	528.1M
Cost of Goods Sold	510.3M	503.1M	463.0M	423.3M	380.2M	358.3M	364.3M	374.3M
Gross Profit	196.3M	205.3M	196.9M	180.0M	178.3M	178.3M	169.0M	153.8M
R&D Expenses	0	0	0	0	0	0	0	0
Operating Expenses	54.8M	52.0M	55.1M	53.7M	64.8M	52.9M	56.7M	48.7M
Operating Income	141.5M	153.3M	141.8M	126.3M	113.5M	125.4M	112.3M	105.2M
Other Income / Gains	6.1M	3.6M	1.0M	-1.8M	4.6M	8.5M	6.5M	5.3M
Net Income	123.9M	135.1M	111.1M	90.3M	114.6M	117.0M	96.4M	88.4M
EPS (Diluted)	4.35	4.78	3.95	3.16	3.77	3.78	3.11	2.85
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.278	0.29	0.298	0.298	0.319	0.332	0.317	0.291
General And Administrative Expenses	0	0	0	0	0	43.9M	0	0
Selling And Marketing Expenses	0	0	0	0	0	1.5M	0	0
Selling General And Administrative Expenses	47.9M	44.9M	48.1M	46.7M	57.9M	45.4M	49.2M	41.5M
Other Expenses	6.9M	7.1M	7.0M	7.0M	6.9M	7.5M	7.5M	7.2M
Cost And Expenses	565.1M	555.2M	518.1M	477.0M	445.0M	411.2M	421.0M	423.0M
Interest Income	5.1M	0	1.5M	1.1M	6.5M	7.9M	7.5M	5.5M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	6.9M	7.1M	7.0M	-6.9M	6.9M	7.5M	7.5M	7.2M
Ebitda	148.4M	164.0M	149.9M	117.6M	120.5M	132.9M	119.8M	112.4M
Ebitdaratio	0.21	0.231	0.227	0.195	0.216	0.248	0.225	0.213
Operating Income Ratio	0.20	0.216	0.215	0.209	0.203	0.234	0.211	0.199
Income Before Tax	147.6M	156.8M	142.8M	124.5M	118.2M	133.9M	118.8M	110.5M
Income Before Tax Ratio	0.209	0.221	0.216	0.206	0.212	0.25	0.223	0.209
Income Tax Expense	23.7M	21.7M	31.7M	34.3M	3.6M	16.9M	22.4M	22.1M
Net Income Ratio	0.175	0.191	0.168	0.15	0.205	0.218	0.181	0.167
Epsdiluted	4.28	4.67	3.87	3.10	3.67	3.67	3.01	2.75
Weighted Average Shs Out	28.4M	28.3M	29.0M	29.5M	30.4M	30.9M	31.0M	31.0M
Weighted Average Shs Out Dil	29.0M	29.0M	29.7M	30.2M	31.2M	32.0M	32.1M	32.1M